Decentralization of HIV care in Cameroon: Increased access to antiretroviral treatment and associated persistent barriers

Health Policy

Volumn 92, Issue 2-3, 2009, Pages 165-173

  Loubiere, Sandrine ^a,b,c   Boyer, Sylvie ^a,b,c   Protopopescu, Camélia ^a,b,c   Bonono, Cécile Renée ^d   Abega, Séverin Cécile ^d   Spire, Bruno ^a,b,c   Moatti, Jean Paul ^a,b,c  

^a AIX MARSEILLE UNIV   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^d Burundi   (Cameroon)

Author keywords

Antiretroviral treatment; Cameroon; Decentralization; Health services; HIV AIDS

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; CAMEROON; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DECENTRALIZATION; FEMALE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE;

ANTI-RETROVIRAL AGENTS; CAMEROON; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; QUESTIONNAIRES; SOCIAL CLASS;

EID: 68949200287     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2009.03.006     Document Type: Article

References (47)

1. Bertozzi S., Gutierrez J.P., Opuni M., Walker N., and Schwartlander B. Estimating resource needs for HIV/AIDS health care services in low-income and middle-income countries. Health Policy 69 (2004) 189-200
2. Desclaux A., Ciss M., Taverne B., Sow P.S., Egrot M., Faye M.A., et al. Access to antiretroviral drugs and AIDS management in Senegal. AIDS 17 Suppl. 3 (2003) S95-S101
3. Lawn S.D., Myer L., Orrell C., Bekker L.G., and Wood R. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 19 (2005) 2141-2148
4. Susman E. Botswana gears up to treat HIV patients in Africa's largest program. AIDS 18 (2004) N1-N2
5. Katzenstein D., Laga M., and Moatti J.P. The evaluation of the HIV/AIDS drug access initiatives in Cote d'Ivoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa. AIDS 17 Suppl. 3 (2003) S1-S4
6. Gilks C.F., Crowley S., Ekpini R., Gove S., Perriens J., Souteyrand Y., et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 368 (2006) 505-510
7. Gruenais M, editor. Changing a health system: the case of Cameroon. In: Euro-African Association for the Anthropology of Social Change and Development. APAD Report no. 21. Paris; 2002.
8. Ministry of Public Health & National AIDS Control Committee. Towards universal access to care and treatment for adults and children living with HIV/AIDS in Cameroo [in French]. In: Progress Report no. 11. Yaoundé, Cameroon; 2008.
9. UNAIDS. Report on the global AIDS epidemic. In: UNAIDS. Geneva; 2008.
10. Badri M., Bekker L.G., Orrell C., Pitt J., Cilliers F., and Wood R. Initiating highly active antiretroviral therapy in sub-Saharan Africa: an assessment of the revised World Health Organization scaling-up guidelines. AIDS 18 (2004) 1159-1168
11. Chadborn T.R., Baster K., Delpech V.C., Sabin C.A., Sinka K., Rice B.D., et al. No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993-2002). AIDS 19 (2005) 513-520
12. Rosen S., Fox M.P., and Gill C.J. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Medicine 4 (2007) e298
13. De Cock K.M., Mbori-Ngacha D., and Marum E. Shadow on the continent: public health and HIV/AIDS in Africa in the 21st century. Lancet 360 (2002) 67-72
14. Girardi E., Sabin C.A., and Monforte A.D. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. Journal of Acquired Immune Deficiency Syndromes 46 Suppl. 1 (2007) S3-S8
15. Person A.K., Ramadhani H.O., and Thielman N.M. Antiretroviral treatment strategies in resource-limited settings. Current HIV/AIDS Reports 4 (2007) 73-79
16. Marcellin F, Abe C, Loubiere S, Boyer S, Blanche J, Koulla-Shiro S, et al. Delayed first consultation after diagnosis of HIV infection in Cameroon. AIDS; Apr 1. [Epub ahead of print].
17. Sow P.S., Otieno L.F., Bissagnene E., Kityo C., Bennink R., Clevenbergh P., et al. Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries. Journal of Acquired Immune Deficiency Syndromes 44 (2007) 262-267
18. Boyer S., Marcellin F., Ongolo-Zogo P., Abega S., Nantchouang R., Spire B., et al. Financial difficulties in accessing HIV care in Yaoundé, Cameroon: first results from the national cross-sectional survey EVAL-ANRS 12-116. Bulletin World Health Organization 87 (2009) 279-287
19. Marcellin F., Boyer S., Protopopescu C., Carrieri M.P., Ongolo-Zogo P., Abega S.C., et al. Risk of antiretroviral treatment interruption among people living with HIV in Yaoundé, Cameroon (EVAL survey ANRS 12-116): determinants, recommendations and possible interventions. Tropical Medicine and International Health 13 (2008) 1470-1478
20. Lawn S.D., Myer L., Bekker L.G., and Wood R. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 21 (2007) 335-341
21. Lawn S.D., and Wood R. Impact of antituberculosis treatment on virological response to highly active antiretroviral therapy: implications for resource-limited settings?. Journal of Infectious Diseases 194 (2006) 1467-1468 author reply 1468
22. Wood R. The case for integrating tuberculosis and HIV treatment services in South Africa. Journal of Infectious Diseases 196 Suppl. 3 (2007) S497-S499
23. Samb B., Celletti F., Holloway J., Van Damme W., De Cock K.M., and Dybul M. Rapid expansion of the health workforce in response to the HIV epidemic. New England Journal of Medicine 357 (2007) 2510-2514
24. Direction de la Statistique et de la Comptabilité Nationale. Enquête à indicateurs multiples, 2000 (MICS 2000) (in French). In: DSCN, Ministère de l'Economie et des Finances. Yaoundé, Cameroun; 2001.
25. Institut National de la Statistique. Deuxième enquête camerounaise auprès des ménages en 2001 (ECAM II 2001)-Conditions de vie des populations et profil de pauvreté au Cameroun en 2001-Rapport principal de l'enquête (in French). In: INS, Ministère de l'Economie et des Finances, République du Cameroun. Yaoundé, Cameroun; 2002.
26. Mukherjee J.S., Ivers L., Leandre F., Farmer P., and Behforouz H. Antiretroviral therapy in resource-poor settings. Decreasing barriers to access and promoting adherence. Journal of Acquired Immune Deficiency Syndromes 43 Suppl. 1 (2006) S123-S126
27. Rosen S., Ketlhapile M., Sanne I., and DeSilva M.B. Cost to patients of obtaining treatment for HIV/AIDS in South Africa. South African Medicine Journal 97 (2007) 524-529
28. Fortson J.G. The gradient in sub-Saharan Africa: socioeconomic status and HIV/AIDS. Demography 45 (2008) 303-322
29. Barnett T., Whiteside A., Khodakevich L., Kruglov Y., and Steshenko V. The HIV/AIDS epidemic in Ukraine: its potential social and economic impact. Social Science and Medicine 51 (2000) 1387-1403
30. Tantchou Yakam J. New actors in the fight against HIV/AIDS: overlapping and competition between existing structures [in French]. La Medicina Tropical 68 (2008) 300-305
31. Tantchou-Yakam J., and Gruenais M. Involving new actors to achieve ART scaling up: difficulties in an HIV/AIDS testing and counselling centre in Cameroon. International Nurse Reviews 56 (2009) 50-57
32. Ainsworth M., Beyrer C., and Soucat A. AIDS and public policy: the lessons and challenges of "success" in Thailand. Health Policy 64 (2003) 13-37
33. El-Sony A.I. The cost to health services of human immunodeficiency virus (HIV) co-infection among tuberculosis patients in Sudan. Health Policy 75 (2006) 272-279
34. Murray C.J., DeJonghe E., Chum H.J., Nyangulu D.S., Salomao A., and Styblo K. Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries. Lancet 338 (1991) 1305-1308
35. WHO. Working together for health. In: The World health report 2006. Geneva; 2006.
36. Hardon A.P., Akurut D., Comoro C., Ekezie C., Irunde H.F., Gerrits T., et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care 19 (2007) 658-665
37. Boyer S., Blanche J., Protopopescu C., Bonono C.R., Marcellin F., Ongolo-Zogo P., et al. Impact of the structural characteristics of healthcare supply in antiretroviral treatment interruption in Cameroon. XVII International AIDS Conference. Mexico City, Mexico, August 3-8, 2008 (2008)
38. Laniece I., Ciss M., Desclaux A., Diop K., Mbodj F., Ndiaye B., et al. Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS 17 Suppl. 3 (2003) S103-S108
39. Weiser S., Wolfe W., Bangsberg D., Thior I., Gilbert P., Makhema J., et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. Journal of Acquired Immune Deficiency Syndromes 34 (2003) 281-288
40. Braitstein P., Brinkhof M.W., Dabis F., Schechter M., Boulle A., Miotti P., et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367 (2006) 817-824
41. Koulla-Shiro S., and Delaporte E. The public health approach to antiretroviral treatment: the case of Cameroon. In: Coriat B. (Ed). The political Economy of HIV/AIDS in developing countries (TRIPS, public health systems and free access) (2008), Edward Elgar, Cheltenham, UK 259-271
42. Bernell S.L., and Shinogle J.A. The relationship between HAART use and employment for HIV-positive individuals: an empirical analysis and policy outlook. Health Policy 71 (2005) 255-264
43. Joy R., Druyts E.F., Brandson E.K., Lima V.D., Rustad C.A., Zhang W., et al. Impact of Neighborhood-Level Socioeconomic Status on HIV Disease Progression in a Universal Health Care Setting. Journal of Acquired Immune Deficiency Syndromes 47 (2008) 500-505
44. UNAIDS. Epidemiological fact sheets on HIV/AIDS and sexually transmitted infections. Cameroon 2006 update (2006), UNAIDS, Geneva
45. Dunne M. Antiretroviral drug development: the challenge of cost and access. AIDS 21 Suppl. 4 (2007) S73-S79
46. Vassall A., and Compernolle P. Estimating the resource needs of scaling-up HIV/AIDS and tuberculosis interventions in sub-Saharan Africa: a systematic review for national policy makers and planners. Health Policy 79 (2006) 1-15
47. Gimbel-Sherr S.O., Micek M.A., Gimbel-Sherr K.H., Koepsell T., Hughes J.P., Thomas K.K., et al. Using nurses to identify HAART eligible patients in the Republic of Mozambique: results of a time series analysis. Human Resource Health 5 (2007) 7